Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).
Current Valuation Ratios
Procter & Gamble Co. | Consumer Staples | ||
---|---|---|---|
Selected Financial Data | |||
Current share price (P) | $170.76 | ||
No. shares of common stock outstanding | 2,355,041,729 | ||
Growth rate (g) | 11.73% | ||
Earnings per share (EPS) | $6.20 | ||
Next year expected EPS | $6.92 | ||
Operating profit per share | $7.87 | ||
Sales per share | $35.68 | ||
Book value per share (BVPS) | $21.35 | ||
Valuation Ratios (Price Multiples) | |||
Price to earnings (P/E) | 27.55 | 32.48 | |
Price to next year expected earnings | 24.66 | 29.82 | |
Price-earnings-growth (PEG) | 2.35 | 3.64 | |
Price to operating profit (P/OP) | 21.68 | 23.74 | |
Price to sales (P/S) | 4.79 | 1.88 | |
Price to book value (P/BV) | 8.00 | 12.21 |
Based on: 10-K (reporting date: 2024-06-30).
If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.
Historical Valuation Ratios (Summary)
Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-30), 10-K (reporting date: 2022-06-30), 10-K (reporting date: 2021-06-30), 10-K (reporting date: 2020-06-30), 10-K (reporting date: 2019-06-30).
Valuation ratio | Description | The company |
---|---|---|
P/E ratio | The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. | Procter & Gamble Co. P/E ratio increased from 2022 to 2023 and from 2023 to 2024. |
P/OP ratio | Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. | Procter & Gamble Co. P/OP ratio increased from 2022 to 2023 and from 2023 to 2024. |
P/S ratio | An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. | Procter & Gamble Co. P/S ratio increased from 2022 to 2023 and from 2023 to 2024. |
P/BV ratio | The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. | Procter & Gamble Co. P/BV ratio increased from 2022 to 2023 and from 2023 to 2024. |
Price to Earnings (P/E)
Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-30), 10-K (reporting date: 2022-06-30), 10-K (reporting date: 2021-06-30), 10-K (reporting date: 2020-06-30), 10-K (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 2024 Calculation
EPS = Net earnings attributable to P&G available to common shareholders ÷ No. shares of common stock outstanding
= 14,595,000,000 ÷ 2,354,050,987 = 6.20
3 Closing price as at the filing date of Procter & Gamble Co. Annual Report.
4 2024 Calculation
P/E ratio = Share price ÷ EPS
= 168.06 ÷ 6.20 = 27.11
Valuation ratio | Description | The company |
---|---|---|
P/E ratio | The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. | Procter & Gamble Co. P/E ratio increased from 2022 to 2023 and from 2023 to 2024. |
Price to Operating Profit (P/OP)
Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-30), 10-K (reporting date: 2022-06-30), 10-K (reporting date: 2021-06-30), 10-K (reporting date: 2020-06-30), 10-K (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 2024 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 18,545,000,000 ÷ 2,354,050,987 = 7.88
3 Closing price as at the filing date of Procter & Gamble Co. Annual Report.
4 2024 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 168.06 ÷ 7.88 = 21.33
Valuation ratio | Description | The company |
---|---|---|
P/OP ratio | Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. | Procter & Gamble Co. P/OP ratio increased from 2022 to 2023 and from 2023 to 2024. |
Price to Sales (P/S)
Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-30), 10-K (reporting date: 2022-06-30), 10-K (reporting date: 2021-06-30), 10-K (reporting date: 2020-06-30), 10-K (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 2024 Calculation
Sales per share = Net sales ÷ No. shares of common stock outstanding
= 84,039,000,000 ÷ 2,354,050,987 = 35.70
3 Closing price as at the filing date of Procter & Gamble Co. Annual Report.
4 2024 Calculation
P/S ratio = Share price ÷ Sales per share
= 168.06 ÷ 35.70 = 4.71
Valuation ratio | Description | The company |
---|---|---|
P/S ratio | An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. | Procter & Gamble Co. P/S ratio increased from 2022 to 2023 and from 2023 to 2024. |
Price to Book Value (P/BV)
Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-30), 10-K (reporting date: 2022-06-30), 10-K (reporting date: 2021-06-30), 10-K (reporting date: 2020-06-30), 10-K (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 2024 Calculation
BVPS = Shareholders’ equity attributable to Procter & Gamble ÷ No. shares of common stock outstanding
= 50,287,000,000 ÷ 2,354,050,987 = 21.36
3 Closing price as at the filing date of Procter & Gamble Co. Annual Report.
4 2024 Calculation
P/BV ratio = Share price ÷ BVPS
= 168.06 ÷ 21.36 = 7.87
Valuation ratio | Description | The company |
---|---|---|
P/BV ratio | The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. | Procter & Gamble Co. P/BV ratio increased from 2022 to 2023 and from 2023 to 2024. |